SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?


To: Bucky Katt who wrote (6505)5/10/1999 1:58:00 AM
From: ~digs  Respond to of 57584
 
Message 9425767
>>>From someone who has lived and worked in China for 2 1/2 years (1996-1998) and
speaks fluent Chinese.

<< unfortunately most American stock market investors - in fact, most Americans -
have absolutely NO idea at all what it is like to "live" and/or INVEST in a
governmentally "controlled" society. we are all - thank God - so use to enjoying SOOO
many freedoms - "paid-for" (BTW) literally via the blood of our fighting forces (both
men and women) - that we simply cannot conceive of - or relate to - what it is really like
to "live" (exist)under such a very brutal and totalitarian controlled government whose
extremely harsh doctrines and dictates are "militarily" enforced upon the people ON A
DAILY BASIS!! >>

While there are many human rights abuses by the Chinese Govt., the average Chinese
citizen's quality of life and freedoms have increased radically since the country started
opening up in 1978. Chinese people can now say what they want to say about the
government(among themselves, not in a public forum). Just a few years ago they would
have been afraid that their "friend" might tell a the government that they were a
subversive and they would subsequently be arrested. People have more and more
freedom of abode. In the recent past it was very difficult for Chinese to move from one
city to another. Now it is relatively easy, and getting easier. The vast majority of the
Chinese people's biggest beef with their government is not their lack of freedoms, but
the rampant government corruption.

Companies that do business and/or have large investments in China:
Proctor and Gamble, Coca Cola, Pepsi, GM, McDonalds, Boeing, Budweiser,
Amway, United Technologies, 3M, Microsoft, etc. This is only a small list of companies
that I thought of off the top of my head.

For people who want more news about China and Chinese Business and Internet please
follow these links:
cnd.org
online.hkstandard.com
chinesebusinessworld.com
redfish.com
deall.ohio-state.edu
china-time.com;




To: Bucky Katt who wrote (6505)5/10/1999 11:34:00 AM
From: brent gephart  Respond to of 57584
 
Medicis Pharmaceutical Announces Board Approval of Stock Repurchase Program

Monday May 10, 10:01 am Eastern Time

Company Press Release

biz.yahoo.com

PHOENIX--(BW HealthWire)--May 10, 1999--Medicis Pharmaceutical Corporation (NYSE:MRX - news) today announced that its board of directors approved a program for the repurchase of up to $75 million of the Company's common stock in the open market or through private transactions. The timing and terms of the purchases will be determined by management based upon market conditions and corporate cash flow requirements. Medicis currently has approximately 28.6 million shares of common stock outstanding.

''Our decision to establish a stock repurchase program at Medicis reflects our confidence in the Company and the strong position we will continue to hold in the rapidly developing pharmaceutical industry,'' said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis.

Medicis is the leading independent pharmaceutical company in the United States focusing primarily on the treatment of dermatological conditions. Medicis develops and markets leading products for major segments within dermatology including acne, psoriasis, eczema, rosacea, dandruff and cosmesis (improvement in the texture and appearance of skin). Primary products include prescription brands DYNACIN®, TRIAZ®, LUSTRA®, LOPROX®, OVIDE®, LIDEX®, SYNALAR®, TOPICORT®, NOVACET®, ZONALON® and A/T/S®; over-the-counter brands ZOSTRIX®, ESOTERICA® and THERAPLEX®; and BUPHENYL(TM), a prescription product indicated in the treatment of Urea Cycle Disorders.

Except for historical information, this news release contains certain forward-looking statements that involve risks and uncertainties which may cause actual results to differ materially from the statements made, including the Company's dependence on sales of key products, uncertainty of future financial results and fluctuations in operating results, dependence on the Company's acquisition strategy, new product introductions and other risks described from time to time in the Company's SEC filings. These forward-looking statements represent the judgment of the Company, as of the date of this release, and Medicis disclaims any intent or obligation to update these forward-looking statements.